The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis

Overview of attention for article published in Journal of Inflammation, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 428)
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 55 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

FUSION PROTEIN INCLUDING GLP-1 RECEPTOR AGONIST AND ANTI-OSCAR ANTIBODY, AND USE THEREOF

Application WO-2022119076-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.